Cystic Fibrosis Treatment Approved for Use in Children Aged 2 to 5 Years
Officials with the FDA have updated the label of lumacaftor/ivacaftor (Orkambi, Vertex Pharmaceuticals), approving the treatment's use in...


Gene Mutations Linked to Other Lung Diseases May Contribute to Bronchiectasis, Study Suggests
Mutations in genes linked to other lung diseases, specifically cystic fibrosis and primary ciliary dyskinesia, may also contribute to...


Arcturus’ RNA Therapy for CF Shows Promise in Preclinical Studies, Company Announces
Arcturus Therapeutics’ RNA-based approach enables the production of healthy CFTR— the protein whose dysfunction is key in cystic fibrosis...


AIT’s Inhaled Nitric Oxide Shows Potential in Fighting Bacterial Infection Prevalent in CF Patients
Inhaled nitric oxide (NO) was shown to be an effective antibacterial agent against Mycobacterium abscessus infection in preclinical...


New Method to Deliver Bacteria-killing Viruses Seen to Resolve Lung Infections in CF Mice
A new therapy which is administered directly into the lung of viruses can kill bacteria, and was shown to be effective in reducing...


Harmful Bacteria Replace Beneficial Ones in Gut of CF Patients, Study Finds
Cystic fibrosis (CF) patients have a higher amount of harmful gut bacteria and increased levels of intestinal inflammation than healthy...


Triclosan, often maligned, may have a good side — treating cystic fibrosis infections
Maybe you’ve had the experience of wading in a stream and struggling to keep your balance on the slick rocks, or forgetting to brush your...


Vertex, NHS England no closer to Orkambi settlement
Vertex and NHS England remain locked in a battle over the provision of cystic fibrosis drug Orkambi, seemingly no closer to a settlement...


Azithromycin Reduced Pulmonary Exacerbation Risk in Cystic Fibrosis
Azithromycin significantly reduced the risk for pulmonary exacerbations and resulted in sustained improvement in weight but had no effect...


Nanoparticles Therapy May Be ‘One-Size-Fits-All’ Approach for CF, Study Suggests
A potential therapy delivered through nanoparticles enables production of the normal, healthy form of the key CFTR protein in cystic...






































